Helios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...

Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...

India's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...

Wockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....

Wockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

The pact was signed following a meeting between Taliban defence minister Mawlawi Mohammad Yaqoob and Sergei Shoigu, secretary of Russia's S...

India, US, Japan, and Australia foreign ministers met in New Delhi. They voiced serious concerns over the South China and East China Seas. ...

US Secretary of State Marco Rubio visits India to forge a new economic alliance. This partnership, driven by leaders like President Trump a...

Five government agencies now require special export licenses for three newly restricted compounds, according to an official announcement on...

Protein-rich foods are becoming more expensive in India. Global supply issues and rising demand are pushing up the cost of whey, a key ingr...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

Indian markets await clarity on Strait of Hormuz shipping. Ashi Anand of IME Capital suggests a defensive market approach. Oil prices near ...

Global capital is shifting towards electronics and AI in Asia. India's foreign direct investment slowdown is not a major concern. Asia's ex...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Indian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United...